Cargando…
Induction of Diabetes Abolishes the Antithrombotic Effect of Clopidogrel in Apolipoprotein E–Deficient Mice
Patients with acute coronary syndrome with diabetes mellitus (DM) exhibit an impaired platelet inhibitory response to clopidogrel which is only partially understood. DM was induced by the administration of streptozotocin (STZ) to 9-week-old mice. The antithrombotic effects of clopidogrel (10 mg/kg/d...
Autores principales: | Sugidachi, A., Ohno, K., Jakubowski, J. A., Ito, Y., Tomizawa, A., Mizuno, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524843/ https://www.ncbi.nlm.nih.gov/pubmed/31249914 http://dx.doi.org/10.1055/s-0037-1605361 |
Ejemplares similares
-
A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats
por: Mizuno, Makoto, et al.
Publicado: (2016) -
Prasugrel, a Platelet P2Y(12) Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia
por: Ohno, Kousaku, et al.
Publicado: (2016) -
Vasodilator-stimulated phosphoprotein (VASP) is not a major mediator of platelet aggregation, thrombogenesis, haemostasis, and antiplatelet effect of prasugrel in rats
por: Ito, Yusuke, et al.
Publicado: (2018) -
High phosphate diet reduces atherosclerosis formation in apolipoprotein E-deficient mice
por: Shiota, Asuka, et al.
Publicado: (2011) -
Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice
por: Du, Fen, et al.
Publicado: (2016)